ArticleBMC ophthalmology2025
Efficacy and safety of 360º and 180º gonioscopy-assisted transluminal trabeculotomy in combination with phacoemulsification in patients with open-angle glaucoma: a retrospective case-control study.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Outcomes of phacoemulsification combined with ab interno trabeculotomy: stratified by incision extent, glaucoma severity, and baseline number of medications.Eye (London, England) · 2026Article
- Two-year clinical outcomes of standalone gonioscopy-assisted transluminal trabeculotomy in normal-tension glaucoma.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare the efficacy and safety of 360º suture gonioscopy-assisted transluminal trabeculotomy (GATT) and 180º GATT (hemi-GATT) combined with cataract surgery in patients with open-angle glaucoma (OAG).
methodsThis single-center retrospective study included patients with OAG treated by GATT or hemi-GATT combined with phacoemulsification with at least six months of follow-up. Outcome measures included change in intraocular pressure (IOP), best-corrected visual acuity (BCVA), and number of glaucoma medications (NGM) used. Success was defined as IOP < 18 mmHg with complete reduction of NGM, or IOP < Pre-Op IOP with complete reduction of NGM, or more than 20% IOP reduction with the same or a smaller number of NGM.
resultsData from 35 patients (mean age = 76 years) and 38 treated eyes were included in this study. The procedural success rate with GATT and hemi-GATT was 94% and 91%, respectively. Average IOP reduced from 17.0 ± 4.8 to 12.9 ± 2.7 mmHg in GATT (Δ=-4.2 mmHg, p = 0.005) and from 17.8 ± 4.9 to 13.8 ± 3.12 mmHg in hemi-GATT (Δ=-4 mmHg, p = 0.002) groups after six months. Average NGM was reduced from 3.5 to 0.3 medications in GATT (Δ=-3.2, p < 0.0001) and from 2.5 to 0.5 medications in hemi-GATT (Δ=-2, p < 0.0001) after six months. There were no serious adverse events in the two study groups.
conclusionGATT and hemi-GATT with concomitant phacoemulsification cataract surgery are equally safe and effective procedures for decreasing IOP and NGM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.